Abstract
Liver metastasis indicates a poor prognosis in patients with advanced or recurrent gastric cancer. Therefore, treatment for a primary lesion of gastric cancer, including gastrectomy and lymphadenectomy, has sometimes not been undertaken because of the presence of liver metastases. New approaches to treat patients with liver metastases, such as hepatic resection, second-generation combination systemic chemotherapy, and hepatic arterial infusion chemotherapy, have sometimes shown good control of liver metastases and have produced long survivals. These advances in the treatment of liver metastases have changed the therapeutic strategy for gastric cancer patients with liver metastases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Yamamura Y, Kito T, Hirai T, et al (1989) Evaluation of treatment for gastric cancer with liver metastasis. Jpn J Gastroenterol Surg 22:2503–2506
Yamamura Y, Kodera Y, Shimizu Y, et al (1998) Management of gastric carcinoma at Aichi Cancer Center: an audit of 4839 cases treated during past 25 years and reports on the recent advances in detection and treatment of distant metastases. Jpn J Gastroenterol Surg 31:2136–2140
Jacques Wils (1996) The treatment of advanced gastric cancer. Semin Oncol 23:397–406
Arai Y, Inaba Y, Takeuchi Y (1997) Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga WR (ed) Interventional radiology, 3rd edn. Williams & Wilkins, Baltimore, pp 192–205
Arai Y, Endo T, Sone Y, et al (1992) Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system. Cancer Chemother Pharmacol 31(suppl I):S99–S102
Arai Y, Sone Y, Tohyama N, et al (1992) Hepatic arterial infusion for unresectable liver metastases from gastric cancer. Proc ASCO 11:176
Ito K, Arai Y, Kumada T, et al (1994) Multi-institutional study of hepatic arterial infusion chemotherapy for liver metastases from gastric cancer using 5-FU, EPIR and MMC. Jpn J Cancer Chemother 30:1377
Horn DC, Stagg RJ, Friedman MA, et al (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 7:1646–1654
Kemeny N, Daly J, Reichman B, et al (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107:459–465
Martin JK, O’Connel MJ, Wieand HS, et al (1990) Intraarterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 125: 1022–1027
Chang AE, Schneider PD, Sugarbaker PH, et al (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685–693
Kemeny MM, Goldberg D, Beatty JD, et al (1986) Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal cancer. Cancer 57:492–498
Rougier P, Laplanche A, Huguier M, et al (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of prospective randomized trial. J Clin Oncol 10:1112–1118
Allen Mersh TG, Earlam S, Fordy C, et al (1994) Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255–1260
Patt YZ (1991) Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J Clin Oncol 11:815–819
Meta-Analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252–258
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Japan
About this chapter
Cite this chapter
Arai, Y. (1999). Management of Liver Metastases. In: Nakajima, T., Yamaguchi, T. (eds) Multimodality Therapy for Gastric Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67927-1_11
Download citation
DOI: https://doi.org/10.1007/978-4-431-67927-1_11
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68009-3
Online ISBN: 978-4-431-67927-1
eBook Packages: Springer Book Archive